Topic: acquisitions

FTC Proposes New HSR Rules for Reporting Pharmaceutical Patent Transfers

by on

Earlier this month, the Federal Trade Commission proposed a new set of reporting requirements for the acquisition or transfer of pharmaceutical patents. From the FTC press release: “The Federal Trade Commission is seeking public comments on proposed changes to the premerger notification rules that could require companies in the pharmaceutical industry to report proposed acquisitions… Read more »

Hospital Mergers Under Increased FTC Scrutiny – What’s the Prognosis?

by on

“According to Chairman Jon Leibowitz, the FTC will continue to scrutinize hospital mergers that could limit patient choice… Based on Chairman Leibowitz’s comments, aggressive and resource-intensive challenges to hospital mergers … are likely to continue.” (Healthcare Tops the Agenda of U.S. Antitrust Enforcers by Morgan Lewis) Hospital mergers are on the rise, and the Federal… Read more »

Browse All Topics